AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 102 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.6%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 2,673,718 | $20,949,000 | 10.15% |
| Vivo Capital, LLC | 3,575,424 | $28,389,000 | 2.57% |
| COWEN AND COMPANY, LLC | 1,517,296 | $10,767,000 | 2.47% |
| VR Adviser, LLC | 1,057,827 | $8,399,000 | 2.28% |
| RTW INVESTMENTS, LP | 4,616,570 | $36,253,000 | 1.56% |
| GENDELL JEFFREY L | 553,516 | $4,395,000 | 1.35% |
| Avoro Capital Advisors LLC | 4,365,655 | $34,663,000 | 1.17% |
| Arlington Capital Management, Inc. | 115,902 | $920,000 | 0.85% |
| Ghost Tree Capital, LLC | 350,000 | $2,779,000 | 0.74% |
| PURA VIDA INVESTMENTS, LLC | 496,660 | $3,943,000 | 0.47% |